Evidence map›Paper›PMID 40455001›Full record

ArticleAntimicrobial agents and chemotherapy2025

Aztreonam plus ceftazidime-avibactam for post-neurosurgical meningitis due to

Jonathan Wong-So, Sophie Magréault, Étienne Carbonnelle, Vincent Jullien, Maxime Desgrouas, Thierry Boulain, François Barbier

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jonathan Wong-SoService de Médecine Intensive Réanimation, Centre Hospitalier Universitaire d'Orleans, Orléans, France.
Sophie MagréaultLaboratoire de Pharmacologie, Hôpital Jean Verdier, Assistance Publique-Hôpitaux de Paris, Paris, France.
Étienne CarbonnelleLaboratoire de Microbiologie, Centre Hospitalier Universitaire d'Orleans, Orléans, France.
Vincent JullienLaboratoire de Pharmacologie, Hôpital Jean Verdier, Assistance Publique-Hôpitaux de Paris, Paris, France.
Maxime DesgrouasService de Médecine Intensive Réanimation, Centre Hospitalier Universitaire d'Orleans, Orléans, France.
Thierry BoulainService de Médecine Intensive Réanimation, Centre Hospitalier Universitaire d'Orleans, Orléans, France.
François BarbierService de Médecine Intensive Réanimation, Centre Hospitalier Universitaire d'Orleans, Orléans, France.ORCID 0000-0002-8447-7265

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical evidence is lacking regarding the efficacy of aztreonam-avibactam in severe infections involving

Indexed as

Anti-Bacterial AgentsAzabicyclo CompoundsAztreonamCeftazidimeGram-Negative Bacterial InfectionsMeningitis, BacterialStenotrophomonas maltophiliaDrug CombinationsHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsAztreonamCeftazidimeDrug Combinationsaztreonamceftazidime-avibactamcentral nervous system infectionsStenotrophomonas maltophiliatherapeutic drug monitoring

Identifiers

PMID40455001
PMCPMC12327007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.